Yi Ning Zhai, Heng Yue Cheng, Jun Ma, Cheng Cheng Feng, Qian Zhang, Wen Bo Bu, Wen Jin Miao, Hui Shen, Chen Ji
{"title":"化脓性汗腺炎中心基因的鉴定与验证。","authors":"Yi Ning Zhai, Heng Yue Cheng, Jun Ma, Cheng Cheng Feng, Qian Zhang, Wen Bo Bu, Wen Jin Miao, Hui Shen, Chen Ji","doi":"10.2147/CCID.S537660","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hidradenitis suppurativa (HS) is a severe, chronic inflammatory disease characterized by inflammatory nodules, progressive sinus tracts, and fistulas. Currently, its pathogenesis remain incompletely understood, and while diverse treatments are available, these have suboptimal efficacy. Herein, we analyzed the relevant genes and pathways in HS using bioinformatics to provide directions for the development of novel treatment.</p><p><strong>Methods: </strong>Two HS datasets were obtained, and differentially expressed genes associated with HS were identified. Enrichment analysis was performed, and a protein-protein interaction network of differential genes was produced. Genes were analyzed using the CytoHubba plugin to obtain the hub genes. For validation, we analyzed the differentially expressed genes between the affected skin tissues of patients with HS and normal human skin tissues.</p><p><strong>Results: </strong>Overall, 180 differential genes associated with HS were identified. Differentially expressed genes were mainly enriched in leukocyte migration, serine hydrolase activity, and serine-type peptidase activity. In total, 69 transcription factors, 115 microRNAs, and 41 drugs associated with hub genes were identified. The expression of <i>FCGR2A</i> and <i>IL2RG</i> was significantly upregulated in the HS disease group compared with that in the normal group.</p><p><strong>Conclusion: </strong>Ten hub genes were identified. Among these, <i>FCGR2A</i> is responsible for the phagocytosis and clearance of immune complexes, the dysregulation of which may represent an important link in the pathogenesis of HS. The PI3K-Akt-mTOR signaling pathway, regulated by the <i>IL2RG</i> gene, showed a close relationship with HS severity and the mechanism of scarring, presenting a potential drug target. The miR-3689 targeting the gene FCGR2A might also be potential biomarkers.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"18 ","pages":"2403-2422"},"PeriodicalIF":2.2000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12478222/pdf/","citationCount":"0","resultStr":"{\"title\":\"Identification and Validation of Hub Genes in Hidradenitis Suppurativa.\",\"authors\":\"Yi Ning Zhai, Heng Yue Cheng, Jun Ma, Cheng Cheng Feng, Qian Zhang, Wen Bo Bu, Wen Jin Miao, Hui Shen, Chen Ji\",\"doi\":\"10.2147/CCID.S537660\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Hidradenitis suppurativa (HS) is a severe, chronic inflammatory disease characterized by inflammatory nodules, progressive sinus tracts, and fistulas. Currently, its pathogenesis remain incompletely understood, and while diverse treatments are available, these have suboptimal efficacy. Herein, we analyzed the relevant genes and pathways in HS using bioinformatics to provide directions for the development of novel treatment.</p><p><strong>Methods: </strong>Two HS datasets were obtained, and differentially expressed genes associated with HS were identified. Enrichment analysis was performed, and a protein-protein interaction network of differential genes was produced. Genes were analyzed using the CytoHubba plugin to obtain the hub genes. For validation, we analyzed the differentially expressed genes between the affected skin tissues of patients with HS and normal human skin tissues.</p><p><strong>Results: </strong>Overall, 180 differential genes associated with HS were identified. Differentially expressed genes were mainly enriched in leukocyte migration, serine hydrolase activity, and serine-type peptidase activity. In total, 69 transcription factors, 115 microRNAs, and 41 drugs associated with hub genes were identified. The expression of <i>FCGR2A</i> and <i>IL2RG</i> was significantly upregulated in the HS disease group compared with that in the normal group.</p><p><strong>Conclusion: </strong>Ten hub genes were identified. Among these, <i>FCGR2A</i> is responsible for the phagocytosis and clearance of immune complexes, the dysregulation of which may represent an important link in the pathogenesis of HS. The PI3K-Akt-mTOR signaling pathway, regulated by the <i>IL2RG</i> gene, showed a close relationship with HS severity and the mechanism of scarring, presenting a potential drug target. The miR-3689 targeting the gene FCGR2A might also be potential biomarkers.</p>\",\"PeriodicalId\":10447,\"journal\":{\"name\":\"Clinical, Cosmetic and Investigational Dermatology\",\"volume\":\"18 \",\"pages\":\"2403-2422\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12478222/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical, Cosmetic and Investigational Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/CCID.S537660\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical, Cosmetic and Investigational Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CCID.S537660","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Identification and Validation of Hub Genes in Hidradenitis Suppurativa.
Background: Hidradenitis suppurativa (HS) is a severe, chronic inflammatory disease characterized by inflammatory nodules, progressive sinus tracts, and fistulas. Currently, its pathogenesis remain incompletely understood, and while diverse treatments are available, these have suboptimal efficacy. Herein, we analyzed the relevant genes and pathways in HS using bioinformatics to provide directions for the development of novel treatment.
Methods: Two HS datasets were obtained, and differentially expressed genes associated with HS were identified. Enrichment analysis was performed, and a protein-protein interaction network of differential genes was produced. Genes were analyzed using the CytoHubba plugin to obtain the hub genes. For validation, we analyzed the differentially expressed genes between the affected skin tissues of patients with HS and normal human skin tissues.
Results: Overall, 180 differential genes associated with HS were identified. Differentially expressed genes were mainly enriched in leukocyte migration, serine hydrolase activity, and serine-type peptidase activity. In total, 69 transcription factors, 115 microRNAs, and 41 drugs associated with hub genes were identified. The expression of FCGR2A and IL2RG was significantly upregulated in the HS disease group compared with that in the normal group.
Conclusion: Ten hub genes were identified. Among these, FCGR2A is responsible for the phagocytosis and clearance of immune complexes, the dysregulation of which may represent an important link in the pathogenesis of HS. The PI3K-Akt-mTOR signaling pathway, regulated by the IL2RG gene, showed a close relationship with HS severity and the mechanism of scarring, presenting a potential drug target. The miR-3689 targeting the gene FCGR2A might also be potential biomarkers.
期刊介绍:
Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions. Normal and pathological processes in skin development and aging, their modification and treatment, as well as basic research into histology of dermal and dermal structures that provide clinical insights and potential treatment options are key topics for the journal.
Patient satisfaction, preference, quality of life, compliance, persistence and their role in developing new management options to optimize outcomes for target conditions constitute major areas of interest.
The journal is characterized by the rapid reporting of clinical studies, reviews and original research in skin research and skin care.
All areas of dermatology will be covered; contributions will be welcomed from all clinicians and basic science researchers globally.